Tissue plasminogen activator prevents white matter damage following stroke.
about
Impacts of tissue-type plasminogen activator (tPA) on neuronal survivalInteractions between age, sex, and hormones in experimental ischemic strokeConformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.White matter injury in ischemic stroke.Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.Neuronal NAMPT is released after cerebral ischemia and protects against white matter injuryPerfusion of ischemic brain in young and aged animals: a laser speckle flowmetry studyRelease of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells.Plasma tPA-Activity and Progression of Cerebral White Matter Hyperintensities in Lacunar Stroke Patients.A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injuryInterleukin-4 Is Essential for Microglia/Macrophage M2 Polarization and Long-Term Recovery After Cerebral Ischemia.Stressed neurons protect themselves by a tissue-type plasminogen activator-mediated EGFR-dependent mechanism.The role of astrocytes in mediating exogenous cell-based restorative therapy for strokeTissue-type plasminogen activator exerts EGF-like chemokinetic effects on oligodendrocytes in white matter (re)myelination.Plasminogen activation and thrombolysis for ischemic stroke.Progesterone and cerebral ischaemia: the relevance of ageing.The immune system in stroke: clinical challenges and their translation to experimental research.Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivotPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.Aging of cerebral white matter.Tissue Plasminogen Activator Expression Is Restricted to Subsets of Excitatory Pyramidal Glutamatergic Neurons.Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.Incidence of seizure in stroke patients treated with recombinant tissue plasminogen activator: A systematic review and meta-analysis.Differential white matter involvement associated with distinct visuospatial deficits after right hemisphere stroke.Traumatic brain injury: tissue-type plasminogen activator--harmful or beneficial?Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke.Protecting Oligodendrocytes by Targeting Non-Glutamate Receptors as a New Therapeutic Strategy for Ischemic Stroke.Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death.Impact of Bradykinin Generation During Thrombolysis in Ischemic Stroke
P2860
Q26777261-83A70B48-8238-4F96-BC5F-39F6445727F4Q26866359-A9161ED6-7581-4AB6-8D71-26725C282CD6Q27329809-12C877F6-6FFF-4299-93CD-C8DCE4500DADQ31080285-1ECBC24B-2A19-45FE-8CBA-90F060865835Q34006140-8A06C67A-0A17-4881-A97E-09C347AE4519Q34727045-77103861-B834-445F-B95D-C86068EDBA76Q35072419-E3638F5D-F9C5-4520-9E02-62350E135ADDQ35924774-91964112-17B8-4086-A0BC-63F00F3B55FAQ35945812-20366BBF-7D59-4947-929B-6A997F216823Q36291166-5ED0EC2C-E2E4-4F78-820A-74DCEF235DD2Q36510329-7DB9C399-F569-4BD9-8CB2-F0C033E4C852Q36751280-D369CA4D-D8D7-46C4-8B15-B09A2FBB7EF2Q37627332-BC830C69-DA51-49E0-81E4-C8F1950F3044Q37661433-756AEEF1-E912-494E-BA2C-44FF3BFFCBB1Q37998537-FC6635FC-5AB8-488D-B947-82E64F4AAEA0Q38103064-13AA9FC3-B10F-425F-AF6D-1A4BCA1A86C9Q38106872-0FDAAA53-62DD-4E8C-BCCC-2C5515F377E2Q38868099-6E98BA02-FCCA-4CB1-8001-C29E6B0F1DC1Q38965982-4E1DD595-0CFC-4F9D-B24A-313373E31B44Q39014387-013A249B-7B79-4D4F-A0AC-A49F7BB1214BQ40532626-CE4A3AFF-E13D-4E9F-AE6D-3386753C069BQ45871638-9D912047-4624-4943-A440-8BCB88518F0FQ48034318-C4BDB28D-7C4F-4F1C-9090-0DD65223FAD9Q48360786-C0037EE5-5352-4341-A57F-46207B12B3D1Q48382272-833BF0C9-A74F-442E-95D7-1A0504CBC2B7Q48558308-DBCFA8E7-09DA-432F-BAF3-B0E8187154ABQ48747959-BCC6E474-AE14-4E22-BAA5-F78DA67F32C5Q50927486-F09FD16C-765F-4486-9D22-CD9ADB722063Q58179635-582C32E8-1B82-4855-92A1-E980020D50B3
P2860
Tissue plasminogen activator prevents white matter damage following stroke.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Tissue plasminogen activator prevents white matter damage following stroke.
@ast
Tissue plasminogen activator prevents white matter damage following stroke.
@en
type
label
Tissue plasminogen activator prevents white matter damage following stroke.
@ast
Tissue plasminogen activator prevents white matter damage following stroke.
@en
prefLabel
Tissue plasminogen activator prevents white matter damage following stroke.
@ast
Tissue plasminogen activator prevents white matter damage following stroke.
@en
P2093
P2860
P50
P356
P1476
Tissue plasminogen activator prevents white matter damage following stroke.
@en
P2093
Axel Montagne
Carmen Guaza
Eric Maubert
Fernando Correa
Jérôme Parcq
Miriam Hernangómez
Pauline Obiang
Richard Macrez
Yannick Hommet
P2860
P304
P356
10.1084/JEM.20101880
P407
P577
2011-05-16T00:00:00Z